EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2024 -0.0002
September 30, 2024 -0.0005
June 30, 2024 -0.0007
March 31, 2024 -0.0012
December 31, 2023 -0.0005
September 30, 2023 -0.0018
June 30, 2023 -0.0007
March 31, 2023 -0.0075
December 31, 2022 -0.0012
September 30, 2022 -0.0009
June 30, 2022 -0.0015
March 31, 2022 -0.0113
December 31, 2021 0.0122
September 30, 2021 -0.0018
June 30, 2021 -0.002
March 31, 2021 -0.0015
December 31, 2020 -0.0021
September 30, 2020 -0.0029
June 30, 2020 -0.0066
March 31, 2020 -0.0313
December 31, 2019 0.0041
September 30, 2019 -0.0106
June 30, 2019 -0.0099
March 31, 2019 -0.0207
December 31, 2018 -0.0169
Date Value
September 30, 2018 -0.0477
June 30, 2018 -0.03
March 31, 2018 -0.07
December 31, 2017 -0.05
September 30, 2017 -0.02
June 30, 2017 -0.02
March 31, 2017 -0.02
December 31, 2016 -0.04
September 30, 2016 -0.04
June 30, 2016 -0.03
March 31, 2016 -0.0349
December 31, 2015 -0.02
September 30, 2015 -0.06
June 30, 2015 -0.03
March 31, 2015 -0.1108
December 31, 2014 -0.02
September 30, 2014 -0.0491
June 30, 2014 -0.40
March 31, 2014 -0.76
December 31, 2013 -0.22
September 30, 2013 0.33
June 30, 2013 -0.0496
March 31, 2013 -0.3696
December 31, 2012 0.10
September 30, 2012 -0.0364

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. -0.2295
CNBX Pharmaceuticals, Inc. -0.0001
Bio-Path Holdings, Inc. -0.0875
Arvinas, Inc. 2.578
Kaleido Biosciences, Inc. --